enGene Therapeutics Inc.
ENGNNASDAQHealthcareBiotechnology
$1.67Today:- (-)1Y −81.71%
As of Oct 16, 2026 close
- Market cap
- $119.25M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.40$12.25
- Volume (live)
- -
- Avg. volume (3M)
- 778.45K
enGene Therapeutics Inc. (ENGN) Dividends
enGene Therapeutics Inc. does not currently pay dividends, or its dividend history is not available.